Document is current

Any future updates will be listed below

Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014

Crossref DOI link: https://doi.org/10.1186/s12885-015-1756-1

Published Online: 2015-10-19

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark